Enterome completes patient enrollment for recurrent glioblastoma study
Enterome has completed patient enrollment in its phase 2 clinical trial (ROSALIE) evaluating its lead…
Enterome has completed patient enrollment in its phase 2 clinical trial (ROSALIE) evaluating its lead…
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…
Clinical stage biopharma company Enterome has presented new data from its two phase 1/2 clinical…
French microbiome biotech Enterome has raised €46.3M in Series E funding to progress its cancer…
New approaches to tame the immune system in the fight against cancer are getting us…
After the success of the world’s first fund dedicated to companies in nutrition, digital health,…
Scientists are uncovering many ways that the microorganisms that share our body can influence our…
The French biotech Enterome and Takeda are teaming up to fight Crohn’s disease, with a…
Enterome will use the money to progress two of its leading microbiome programs for the…
Microbiome Diagnostics Partners will develop diagnostics tests with Enterome's microbiome platform IP and a €20M…
A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how…
Yesterday, a panel of experts at BioTrinity discussed the huge possibilities offered by the young…